Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13
Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
4,407 | Dovepress* | 3,381 | 569+ | 917 | 3,950 |
PubMed Central* | 0 | 457 | 126 | 457 | |
Totals | 3,381 | 1,026 | 1,043 | 4,407 | |
*Since 18 October 2018 +Since July 2016 |
View citations on PubMed Central and Google Scholar